PUF-SCS effectively suppressed sympathetic tone and reduced ventricular arrhythmia burden without causing permanent damage to the sympathetic ganglia. In the MI model, heart function and ventricular fibrillation vulnerability were reversed 1 month after PUF-SCS.
Lin et al. (2026) studied this question.